Glycosylation is a critical process in both health and disease, involving the addition of carbohydrates to proteins and lipids to form glycoconjugates. These glycoconjugates play essential roles in cellular functions, including immune responses, inflammation, and cancer progression. Glycosylation patterns are altered in various diseases, such as congenital disorders of glycosylation (CDGs), autoimmune diseases, and chronic inflammatory conditions. Understanding these changes can lead to new diagnostic approaches and therapeutic strategies. Glycosylation occurs in different forms, including N-linked and O-linked glycosylation, which are crucial for the structure and function of proteins and lipids. N-linked glycosylation involves the addition of N-acetylglucosamine (GlcNAc) to the nitrogen atom of an Asn residue, while O-linked glycosylation involves the addition of sugars to the oxygen atom of Ser or Thr residues. These glycosylation patterns can influence the behavior of cells, including immune cell interactions, cancer metastasis, and apoptosis. Glycosylation is a dynamic process that depends on the local environment of enzymes, sugar precursors, and organelles. The glycome, which refers to the complete set of glycoconjugates in a cell, reflects the cell's gene expression pattern and is intricately regulated in the endoplasmic reticulum (ER) and Golgi apparatus. The glycome has significant implications for health and disease, as changes in glycosylation can modulate inflammatory responses, enable viral immune escape, promote cancer cell metastasis, and regulate apoptosis. Recent advances in glycobiology have improved our understanding of the glycome's heterogeneity and complexity, enabling researchers to assess how the secreted and cell-surface glycomes reflect overall cellular status. These insights have led to the development of glycomedicine, an emerging field that applies glycosylation knowledge to therapy development. For example, glycoengineering of therapeutic antibodies can enhance their anti-inflammatory properties or improve their ability to target cancer cells. Glycosylation also plays a crucial role in immunity and inflammation. Glycan-binding proteins and other molecules help immune cells recognize pathogen-associated molecular patterns, which is essential for vaccine development. Additionally, glycosylation influences immune cell trafficking and interactions, as well as the function of immunoglobulins in humoral immunity. Abnormal glycosylation patterns have been associated with chronic inflammatory, autoimmune, and infectious diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and HIV infection. In cancer, glycosylation changes are often observed, including increased sialyl Lewis structures, abnormal core fucosylation, and the exposure of mucin-type O-glycans. These changes can facilitate cancer cell metastasis and resistance to chemotherapy. The study of these glycosylation changes is essential for understanding cancer progression and developing new therapeutic strategies. Overall, glycosylation is a vital process that influencesGlycosylation is a critical process in both health and disease, involving the addition of carbohydrates to proteins and lipids to form glycoconjugates. These glycoconjugates play essential roles in cellular functions, including immune responses, inflammation, and cancer progression. Glycosylation patterns are altered in various diseases, such as congenital disorders of glycosylation (CDGs), autoimmune diseases, and chronic inflammatory conditions. Understanding these changes can lead to new diagnostic approaches and therapeutic strategies. Glycosylation occurs in different forms, including N-linked and O-linked glycosylation, which are crucial for the structure and function of proteins and lipids. N-linked glycosylation involves the addition of N-acetylglucosamine (GlcNAc) to the nitrogen atom of an Asn residue, while O-linked glycosylation involves the addition of sugars to the oxygen atom of Ser or Thr residues. These glycosylation patterns can influence the behavior of cells, including immune cell interactions, cancer metastasis, and apoptosis. Glycosylation is a dynamic process that depends on the local environment of enzymes, sugar precursors, and organelles. The glycome, which refers to the complete set of glycoconjugates in a cell, reflects the cell's gene expression pattern and is intricately regulated in the endoplasmic reticulum (ER) and Golgi apparatus. The glycome has significant implications for health and disease, as changes in glycosylation can modulate inflammatory responses, enable viral immune escape, promote cancer cell metastasis, and regulate apoptosis. Recent advances in glycobiology have improved our understanding of the glycome's heterogeneity and complexity, enabling researchers to assess how the secreted and cell-surface glycomes reflect overall cellular status. These insights have led to the development of glycomedicine, an emerging field that applies glycosylation knowledge to therapy development. For example, glycoengineering of therapeutic antibodies can enhance their anti-inflammatory properties or improve their ability to target cancer cells. Glycosylation also plays a crucial role in immunity and inflammation. Glycan-binding proteins and other molecules help immune cells recognize pathogen-associated molecular patterns, which is essential for vaccine development. Additionally, glycosylation influences immune cell trafficking and interactions, as well as the function of immunoglobulins in humoral immunity. Abnormal glycosylation patterns have been associated with chronic inflammatory, autoimmune, and infectious diseases, such as rheumatoid arthritis, systemic lupus erythematosus, and HIV infection. In cancer, glycosylation changes are often observed, including increased sialyl Lewis structures, abnormal core fucosylation, and the exposure of mucin-type O-glycans. These changes can facilitate cancer cell metastasis and resistance to chemotherapy. The study of these glycosylation changes is essential for understanding cancer progression and developing new therapeutic strategies. Overall, glycosylation is a vital process that influences